Scientific work

Prof. Dr. Saadettin Kılıçkap

479 publications. The source of the information is stated next to each publication.

Back to profile

  1. Drug-related problems with targeted/immunotherapies at an oncology outpatient clinic

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219861679 PMID 31342849 9 citations (Europe PMC) Source: ORCID

  2. Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19

    Frontiers in Oncology, 2020

    DOI 10.3389/fonc.2020.01553 PMID 33014800 46 citations (Europe PMC) Open-access full textSource: ORCID

  3. Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: Current status and future perspectives

    Biomarkers in Medicine, 2020

    DOI 10.2217/bmm-2020-0310 PMID 33064030 17 citations (Europe PMC) Source: ORCID

  4. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219840796 PMID 30924738 10 citations (Europe PMC) Source: ORCID

  5. Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

    BMC Cancer, 2020

    DOI 10.1186/s12885-020-06758-9 PMID 32228512 11 citations (Europe PMC) Open-access full textSource: ORCID

  6. Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study

    Supportive Care in Cancer, 2020

    DOI 10.1007/s00520-019-04879-x PMID 31127438 9 citations (Europe PMC) Source: ORCID

  7. Survey of the impact of COVID-19 on oncologists' decision making in cancer

    JCO Global Oncology, 2020

    DOI 10.1200/go.20.00300 PMID 32755479 36 citations (Europe PMC) Open-access full textSource: ORCID

  8. The impact of everolimus and radiation therapy on pulmonary fibrosis

    Medicina (Lithuania), 2020

    DOI 10.3390/medicina56070348 PMID 32668776 3 citations (Europe PMC) Open-access full textSource: ORCID

  9. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases

    Journal of B.U.ON., 2020

    Source: ORCID

  10. Hacettepe Dahiliye Ders Kitabı 2

    Hacettepe Üniversitesi eBooks, 2020

    Source: OpenAlex

  11. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.

    Journal of Clinical Oncology, 2020

    DOI 10.1200/jco.2020.38.6_suppl.451 3 citations (OpenAlex) Source: OpenAlex

  12. P-209 Multicenter real life experience of biological agents in patients with metastatic colorectal cancer

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.04.291 Open-access full textSource: OpenAlex

  13. CANCER EPIDEMIOLOGY IN ELDERLY PATIENTS

    Turkiye Klinikleri eBooks, 2020

    DOI 10.5336/978-625-401-191-7_p1 1 citation (OpenAlex) Source: OpenAlex

  14. Evaluation of emergency department visits in patients treated with immune checkpoint inhibitors.

    Journal of Clinical Oncology, 2020

    DOI 10.1200/jco.2020.38.15_suppl.e24160 1 citation (OpenAlex) Source: OpenAlex

  15. 1546P Prognostic role of tumoral DNA damage repair protein expression in patients with resectable pancreatic cancer

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.2029 Open-access full textSource: OpenAlex

  16. 1763P Daily chemotherapy and treatment unit in the COVID-19 era: Lessons of the first 60 days

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.1827 Open-access full textSource: OpenAlex

  17. 98P Low prognostic nutritional index is independently associated with poorer survival in patients receiving immune checkpoint inhibitors

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.10.587 Open-access full textSource: OpenAlex

  18. Yaşlılarda Kanser Epidemiyolojisi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2020

    Source: OpenAlex

  19. 1724P Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.1788 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  20. LBA52 EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.2285 28 citations (OpenAlex) Open-access full textSource: OpenAlex

  21. Multi-dimensional evaluation of daily living activities in lung cancer

    European Respiratory Journal, 2020

    DOI 10.1183/13993003.congress-2020.2931 2 citations (OpenAlex) Source: OpenAlex

  22. FRI0207 CANCER INCIDENCE AND FEATURES IN ADULT VASCULITIS PATIENTS

    Annals of the Rheumatic Diseases, 2020

    DOI 10.1136/annrheumdis-2020-eular.2575 Open-access full textSource: OpenAlex

  23. SAT0243 SUBPHENOTYPES IN POLYARTERITIS NODOSA (PAN): TARGET ORGAN ASSOCIATIONS OF A WORLDWIDE COLLABORATION STUDY

    Annals of the Rheumatic Diseases, 2020

    DOI 10.1136/annrheumdis-2020-eular.4635 Source: OpenAlex

  24. Akciğer Kanseri Hastasının Takibi

    2020

    Source: OpenAlex

  25. Relationship of Respiratory Muscle Endurance Workload with Maximal Oxygen Consumption and Fatigue in Individuals Surviving Colorectal Cancer

    European Respiratory Journal, 2020

    DOI 10.1183/13993003.congress-2020.2971 Source: OpenAlex

  26. Evaluation of functional exercise capacity using two-field test in lung cancer patients

    European Respiratory Journal, 2020

    DOI 10.1183/13993003.congress-2020.278 Source: OpenAlex

  27. 99P The association between antibiotic use and survival in renal cell carcinoma patients treated with nivolumab: A multi-center study

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.10.588 Open-access full textSource: OpenAlex

  28. İş Sağlığı ve Güvenliği Meslek Hastalıkları

    Hacettepe University Institutional Repository (hacettepe.edu.tr), 2020

    Open-access full textSource: OpenAlex

  29. Hacettepe Dahiliye Ders Kitabı 1

    Hacettepe Üniversitesi eBooks, 2020

    Source: OpenAlex

  30. P2.17-23 The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1934 Open-access full textSource: OpenAlex

  31. P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1166 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  32. Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz260.069 Open-access full textSource: OpenAlex

  33. The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219883004 PMID 31653193 17 citations (Europe PMC) Source: OpenAlex

  34. Analysis of FUSOBACTERIUM NUCLEATUM and Streptococcus Gallolyticus in Saliva of Colorectal Cancer Patients

    Biomarkers in Medicine, 2019

    DOI 10.2217/bmm-2019-0020 PMID 31157977 34 citations (Europe PMC) Source: OpenAlex

  35. Adaptation of error adjusted bagging method for prediction

    International Journal of Data Warehousing and Mining, 2019

    DOI 10.4018/ijdwm.2019070102 Source: ORCID

  36. Bone Marrow Micrometastases and Circulating Tumor Cells

    Breast Disease: Diagnosis and Pathology, Volume 1: Second Edition, 2019

    DOI 10.1007/978-3-030-04606-4_13 1 citation (OpenAlex) Source: ORCID

  37. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155218805539 PMID 30400750 5 citations (Europe PMC) Source: ORCID

  38. Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219858176 PMID 31226917 Source: ORCID

  39. Reproductive cancer risk factors among relatives of cancer patients in a tertiary oncology center

    BMC Cancer, 2019

    DOI 10.1186/s12885-019-5350-9 PMID 30770749 Open-access full textSource: ORCID

  40. Short-time use of crizotinib as neoadjuvant in ALK-positive non-small cell lung carcinoma can be a chance for resectability

    Cancer Chemotherapy and Pharmacology, 2019

    DOI 10.1007/s00280-019-03810-9 PMID 30863883 6 citations (Europe PMC) Source: ORCID

  41. Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)

    Clinical and Experimental Rheumatology, 2019

    Source: ORCID

  42. THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)

    Annals of the Rheumatic Diseases, 2019

    DOI 10.1136/annrheumdis-2019-eular.2707 18 citations (OpenAlex) Open-access full textSource: OpenAlex

  43. THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY)

    Annals of the Rheumatic Diseases, 2019

    DOI 10.1136/annrheumdis-2019-eular.2870 9 citations (OpenAlex) Open-access full textSource: OpenAlex

  44. Clinical features and prognosis of patients with liposarcoma: Single-center experience.

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.15_suppl.e22557 Source: OpenAlex

  45. Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz261.017 Open-access full textSource: OpenAlex

  46. Global Epidemiology of Gastrointestinal Cancers

    Springer eBooks, 2019

    DOI 10.1007/978-3-030-18890-0_1 13 citations (OpenAlex) Source: OpenAlex

  47. P2.01-01 Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 ≥50%

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1345 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  48. Critical Role of Ga–68 DOTATATE PET-CT in a Patient with Neuroendocrine Tumor and Second Primary Cancer

    Endocrinology research and practice., 2019

    DOI 10.25179/tjem.2018-62733 Open-access full textSource: OpenAlex

  49. BRAF Mutant Metastatik Melanom Tedavisinde Güncel Yaklaşımlar

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source: OpenAlex

  50. The Relationship between Work of Walking and Respiratory Muscle Strength in Patients with Lung Cancer

    Turkish Thoracic Journal, 2019

    DOI 10.5152/turkthoracj.2019.417 Open-access full textSource: OpenAlex